This is what a lot of patients have been waiting for: credentis, the med-tech start-up from Aargau, has developed a product decreasing dentine hypersensitivity and making dental hygiene treatment more pleasant.
Today credentis has launched its new product CURODONT D’SENZ, optimised for the treatment of dentine hypersensitivity. The product is to be used before dental hygiene treatment or in conjunction with tooth bleaching.
In connection with the launch, the clinical study performed at the Prophylaxe Zentrum Zürich with principle investigator Prof. Dr. Ulrich P. Saxer has been presented. The data show that CURODONT D’SENZ when applied before dental hygiene treatment makes the treatment more pleasant for the patient and easier for the hygienist. In addition, CURODONT D’SENZ decreases the dentine hypersensitivity for more than 80% of the patients.
CURODONT D’SENZ is the result of numerous feedbacks credentis has received over the past year, saying that CURODONT PROTECT when applied before treatment allows a more pleasant dental cleaning. “I am confident that both patients and hygienists will benefit from using CURODONT D’SENZ”, says Prof. Saxer.
About credentis ag
credentis ag is headquartered in the Technopark, Aargau, Switzerland. credentis has won multiple awards as well as support from organizations such as Genilem. Public grants include Swiss National Science Foundation (SNSF), Aargauer Forschungsfonds in collaboration with the FHNW School of Life Sciences in Muttenz and the Medical Technologies IKC (in co-operation with the University of Leeds).
Dr. Dominik Lysek, CEO and Michael Hug, CTO have a strong track record in science, development and medical technology, with focus in the dental industry. credentis board members Dr. Werner Berner, Dr. Michael Peetz, Gerard Moufflet and Dr. Erich Platzer (chairman), contribute their pharma, medtech and dental industry expertise.
Please login or sign up to comment.
Commenting guidelines